Therapeutic Ultrasound with Piezo Components

Ultrasound opens up new and innovative therapeutic possibilities that improve or even substitute many established procedures: Minimally invasive and gentle treatment methods with improved therapy success and fewer side effects can be realized using piezo components.


Therapeutic ultrasound refers to methods in which ultrasound is not only a means of diagnosis but also the core element of the therapy, e. g. tissue ablation, targeted drug delivery, ultrasound-assisted thrombolysis, and lithotripsy.


Find out more on therapeutic ultrasound with piezos

HIFU can also be used to treat tremor or epilepsy without medication by targeting specific brain structures with heat.

HIFU for Noncontact Tissue Ablation

The ultrasound-based ablation of tissue, for example for the removal of tumors in the prostate or uterus, is carried out extracorporeal and is thus noninvasive. For this therapy, high-intensity focused ultrasound (HIFU) is projected into the body with the help of piezoelectric elements. Piezo discs, plates, and focus bowls by PI Ceramic are manufactured in customer-specific geometries and electrode designs and are ideally suited for building HIFU transducers.


In order to generate a directed wave, several of the piezoelectric elements are arranged on a spherical dome and excited synchronously to focus the energy in the shock wave.


These acoustic waves have various effects in the body: In histotripsy, ultrasound produces cavitation bubbles whose mechanical energy causes cells to burst. Thermal ablation using ultrasound generates heat of over 42°C by absorbing the wave energy so that the proteins of the cell structures become denaturated and entire tissue areas are coagulated in the sound focus.

Targeted Drug Delivery:

Drug Application within the Body

Another use case for HIFU generation with piezoelectric discs, plates, and focus bowls are targeted drug delivery procedures. Using HIFU, drugs can be released or activated at a specific site in the body.


The basic method is the injection of microspheres filled with medication or gas, which are distributed in the patient's bloodstream during treatment and are only used where they are in the sound field focus.


An unstable cavitation caused by ultrasound causes the microspheres to burst and the medication to be released locally.

Gas-filled microspheres can be injected to increase the uptake of therapeutic substances.

Ultrasound waves created by tiny piezoelectric elements increase the permeability of the blood vessel wall.

Intravascular Lithotripsy with Miniaturized Piezo Components

Intravascular lithotripsy is used in a minimally invasive way to reduce atherosclerotic plaques in blood vessels or at the heart valves as well as life-threatening stenoses.


Ultrasound waves increase the permeability of the blood vessel wall through sonoporation so that the medication can penetrate better and induce the dissolution of plaques.

If a thrombus has already formed, its structure can be loosened with the help of mechanical ultrasound energy.


This makes it easier for drugs to penetrate into the thrombus and dissolve it, ensuring the flow of blood to vital organs and preventing embolisms.


Miniaturized piezo tubes or tiny plates are used for intravascular lithotripsy and thrombectomy applications as they can generate ultrasound waves even when integrated into the finest catheters.


PI Ceramic manufactures piezo elements with dimensions of less than one millimeter.

About PI Ceramic GmbH

Redefining the limits of what can be measured and moved, together with our customers: As a worldwide partner with more than 25 years of expertise, PI Ceramic develops and manufactures sophisticated piezoceramic components and subsystems in the areas of medical technology, industrial ultrasonic sensors and precision dosing. Seventy of the currently 320 employees at the location in Thuringia, Germany, work in research and development. PI Ceramic is part of the PI Group, the innovation and market leader for high-precision positioning technology.

BACK TO TOP 

Go to article: Home | Should patients be told about AI in healthcare?Go to article: In this issueGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: ContentsGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: Apple RubberGo to article: Swisstec 3DGo to article: SemecsGo to article: BriefingGo to article: Industry newsGo to article: Covid-19 executive briefing by GlobalDataGo to article: The medical industry briefingGo to article: Micro Systems TechnologiesGo to article: Erdmann Design Company Insight Go to article: Erdmann Design Go to article: Tricor SystemsGo to article: Senstech Company Insight Go to article: SenstechGo to article: GS SwissGo to article: Fisba Go to article: Industrial Indexing Systems Company InsightGo to article: Industrial Indexing SystemsGo to article: CommentGo to article: Smart glasses could be vital for Covid-19 patient careGo to article: Covid-19 antigen tests will increase testing ability in the USGo to article: New study to improve existing telehealth servicesGo to article: Republican FDA reform: What does this mean for medical devices?Go to article: Election outcomes that would result in a lowering of healthcare costsGo to article: Five ways we can ensure patient data anonymity is preservedGo to article: Can a t-shirt provide continuous patient monitoring?Go to article: Q&A: a ‘Zoom for medics’ with Visionable Go to article: Elkem Company Insight Go to article: ElkemGo to article: Mi3 Medical IntelligenceGo to article: uvexGo to article: PI Ceramic Company Insight Go to article: PI CeramicGo to article: IWA ConsultingGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: MelexisGo to article: In DepthGo to article: Check-Cap: rethinking the colonoscopyGo to article: Blood collection anytime, anywhereGo to article: A matter of life and death: building a consensus on brain deathGo to article: Artificial consent: should doctors be telling patients more about AI?Go to article: Fertile ground for artificial intelligence in IVFGo to article: How disruptive has 2020 been for med tech?Go to article: Biesterfeld Go to article: Medica Company Insight Go to article: Medica Go to article: Caeleste Company Insight Go to article: CaelesteGo to article: Eastprint IncorporatedGo to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: SannerGo to article: Frankfurt Laser Company InsightGo to article: WatlowGo to article: UltraFast InnovationsGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The medical industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: TS Quality & EngineeringGo to article: General PlasticsGo to article: CorTec Go to article: SanminaGo to article: ProByLas Go to article: EventsGo to article: Omnitron Go to article: INDO-MIMGo to article: KSP Go to article: AccumoldGo to article: Chromatic 3D MaterialsGo to article: CoherentGo to article: Next issueGo to article: ESMAGo to article: ICF MercantileGo to article: mdi ConsultantsGo to article: SIM AutomationGo to article: maxonGo to article: Nelson Labs